Evelyn Partners Group Ltd’s AbbVie ABBV Stock Holding History

Evelyn Partners Group Ltd’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.47M	Buy	+9,801	New	+$2.11M	0.01%	131

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Evelyn Partners Group Ltd's ABBV Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in AbbVie (ABBV) in Q2 2026: 9,801 shares worth $2.47M. The stake represents 0.01% of the portfolio and ranks #131 among its holdings.

2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Evelyn Partners Group Ltd held 9,801 shares of AbbVie worth $2.47M as of Q2 2026.
AbbVie was a new Evelyn Partners Group Ltd position in Q2 2026.
AbbVie made up 0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #131 holding.
2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.